Man Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $495K | Sell |
2,336
-95,848
| -98% | -$18.8M | ﹤0.01% | 2066 |
|
|
2026
Q1 | $19.2M | Buy |
98,184
+17,994
| +22% | +$3.5M | 0.03% | 516 |
|
|
2025
Q4 | $13.9M | Buy |
80,190
+77,686
| +3,102% | +$14.1M | 0.02% | 653 |
|
|
2025
Q3 | $477K | Sell |
2,504
-487
| -16% | -$86.4K | ﹤0.01% | 1867 |
|
|
2025
Q2 | $537K | Sell |
2,991
-14,206
| -83% | -$2.47M | ﹤0.01% | 1810 |
|
|
2025
Q1 | $2.91M | Sell |
17,197
-19,314
| -53% | -$3.17M | 0.01% | 1219 |
|
|
2024
Q4 | $5.51M | Sell |
36,511
-75,392
| -67% | -$11.7M | 0.01% | 979 |
|
|
2024
Q3 | $17.4M | Sell |
111,903
-84,173
| -43% | -$12.6M | 0.05% | 500 |
|
|
2024
Q2 | $26.8M | Buy |
196,076
+15,978
| +9% | +$2.19M | 0.07% | 344 |
|
|
2024
Q1 | $24M | Buy |
180,098
+124,330
| +223% | +$16.1M | 0.06% | 366 |
|
|
2023
Q4 | $7.69M | Buy |
+55,768
| New | +$7.33M | 0.02% | 771 |
|
|
2023
Q3 | – | Sell |
-116,359
| Closed | -$15.5M | – | 513 |
|
|
2023
Q2 | $16.4M | Buy |
+116,359
| New | +$16M | 0.05% | 443 |
|
|
2023
Q1 | – | Sell |
-190,434
| Closed | -$27.2M | – | 176 |
|
|
2022
Q4 | $29.8M | Buy |
190,434
+85,336
| +81% | +$12.3M | 0.11% | 238 |
|
|
2022
Q3 | $12.9M | Buy |
+105,098
| New | +$13.8M | 0.06% | 391 |
|
|
2022
Q2 | – | Sell |
-101,046
| Closed | -$13.8M | – | 538 |
|
|
2022
Q1 | $13.8M | Buy |
101,046
+13,882
| +16% | +$1.93M | 0.05% | 470 |
|
|
2021
Q4 | $15.1M | Sell |
87,164
-822
| -0.9% | -$125K | 0.05% | 463 |
|
|
2021
Q3 | $12.8M | Sell |
87,986
-20,799
| -19% | -$3.04M | 0.04% | 480 |
|
|
2021
Q2 | $14.4M | Sell |
108,785
-168,573
| -61% | -$22.1M | 0.05% | 430 |
|
|
2021
Q1 | $35.6M | Buy |
277,358
+113,036
| +69% | +$13.9M | 0.16% | 138 |
|
|
2020
Q4 | $19.6M | Buy |
164,322
+83,855
| +104% | +$10.2M | 0.09% | 226 |
|
|
2020
Q3 | $9.21M | Buy |
80,467
+48,895
| +155% | +$5.78M | 0.04% | 507 |
|
|
2020
Q2 | $3.6M | Sell |
31,572
-100,725
| -76% | -$10.7M | 0.02% | 822 |
|
|
2020
Q1 | $10.6M | Sell |
132,297
-58,268
| -31% | -$6.03M | 0.07% | 272 |
|
|
2019
Q4 | $20.4M | Buy |
190,565
+103,638
| +119% | +$10.8M | 0.07% | 345 |
|
|
2019
Q3 | $9.3M | Sell |
86,927
-66,630
| -43% | -$6.84M | 0.03% | 617 |
|
|
2019
Q2 | $15.6M | Buy |
153,557
+9,388
| +7% | +$902K | 0.06% | 431 |
|
|
2019
Q1 | $13M | Sell |
144,169
-966
| -0.7% | -$83.7K | 0.05% | 462 |
|
|
2018
Q4 | $12.1M | Sell |
145,135
-66,571
| -31% | -$6.24M | 0.05% | 393 |
|
|
2018
Q3 | $22.8M | Buy |
211,706
+35,376
| +20% | +$3.88M | 0.08% | 275 |
|
|
2018
Q2 | $19.4M | Buy |
176,330
+33,188
| +23% | +$3.46M | 0.08% | 275 |
|
|
2018
Q1 | $14.4M | Buy |
+143,142
| New | +$14.7M | 0.07% | 333 |
|
Other funds holding DGX
EIG
Man Group's DGX Position: Q2 2026 in Review
Man Group reduced its Quest Diagnostics (DGX) stake by 98% in Q2 2026, selling an estimated $18.8M and leaving 2,336 shares worth $495K. The position accounts for ﹤0.01% of the portfolio, ranked #2066.
Man Group first reported a position in DGX in Q1 2018 and has held it in 31 quarters since. The position peaked at $35.6M in Q1 2021. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Man Group held 2,336 shares of Quest Diagnostics worth $495K as of Q2 2026.
- Man Group sold 95,848 Quest Diagnostics shares in Q2 2026, an estimated $18.8M.
- Quest Diagnostics made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2066 holding.
- Man Group first reported a position in Quest Diagnostics in Q1 2018 and has held it in 31 quarters since.
- Man Group's Quest Diagnostics position peaked at $35.6M in Q1 2021.
- 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.